人民财讯1月7日电，华康洁净（301235）1月7日公告，股东阳光（600673）人寿保险股份有限公司计划 减持不超过313.11万股，占剔除公司回购专用账户股份后总股本的3%。减持方式为集中竞价交易和大 宗交易。 ...

Group 1 - The core point of the article is that Huakang Clean (301235) announced that its shareholder Sunshine Life Insurance Co., Ltd. plans to reduce its holdings by no more than 3.1311 million shares, which accounts for 3% of the total share capital after excluding shares in the company's repurchase account [1] - The reduction will be executed through centralized bidding and block trading methods [1] - The reason for the reduction is stated as operational development needs, with the reduction period set from January 13, 2026, to April 12, 2026, which is three months after the announcement [1]

转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2026-003 武汉华康世纪洁净科技股份有限公司 关于股东减持股份的预披露公告 公司股东阳光人寿保险股份有限公司保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 公司于近日收到股东阳光人寿出具的《关于股份减持计划的告知函》，现将有关 情况公告如下： 一、股东基本概况 阳光人寿持有公司股份4,527,646股，占本公司总股本（截至2026年1月6日总股 本为107,774,549股）比例为4.2010%，占剔除公司回购专用账户股份后总股本的 4.3380%（公司回购专用账户股份数为3,403,400股），股票来源为首次公开发行前已 发行的股份，均为无限售流通股。 二、本次股东减持计划的主要内容 1、减持目的：经营发展需要； 2、股份来源：公司首次公开发行股票前已发行的股份； 3、减持方式：证券交易所集中竞价交易、大宗交易； 4、拟减持股份数量及比例：阳光人寿拟减持股份数量不超过3,131,134股，减持 比例不超 ...

Core Viewpoint - The collaboration between Huakang Clean and Jiufengshan Laboratory is expected to deeply integrate local high-quality resources, marking the company's significant involvement in the "chip" industry ecosystem of Optics Valley [1] Group 1: Collaboration and Innovation - The partnership aims to combine Jiufengshan Laboratory's R&D innovation resources with the company's expertise in semiconductor clean environments to build an industrial innovation consortium [1] - This initiative is set to establish a benchmark for the compound semiconductor industry, supporting the development of a world-class industrial cluster in Wuhan's Optics Valley and contributing to the national strategic emerging industries [1] Group 2: Market Opportunities - The collaboration with a key local semiconductor R&D innovation center is expected to attract numerous potential clients in the electronic clean sector [1] - By entering the electronic clean market, the company is opening a second growth curve, with prospects for sustained high growth in its electronic clean business due to local resource advantages and expansion beyond the province [1]

与本地重要半导体实验室合作，公司获客能力有望提升公司已与九峰山实验室正式达成战略合作，成为 其合作伙伴及九峰山论坛的三年重要赞助单位。双方将围绕资源整合、优势互补与生态共建，以九峰山 论坛为核心载体，在平台共建、活动共办、技术共研及产业链对接等多个维度开展深度协作。合作标志 着公司深度融入光谷"芯"产业生态，旨在结合九峰山实验室的研发创新资源与公司在半导体洁净环境的 专业能力，共同构建产业创新联合体，打造化合物半导体产业的标杆，为武汉光谷建设世界级产业集 群、支撑国家战略性新兴产业发展提供动力与示范。我们认为，公司与本地重要半导体研发创新中心合 作，有望在电子洁净领域迎来众多潜在客户。 前三季度业绩亮眼，主要受益于净化系统完工项目增多2025Q1-3 公司实现营业收入14.31 亿元 （+32.59%），归母净利润0.61 亿元（+211.46%），扣非净利润0.61 亿元（+365.18%）。分季度来看， 2025Q1、Q2、Q3 营业收入分别为2.95 亿元（+28.54%）、5.40亿元（+66.45%）、5.97 亿元 （+13.48%），归母净利润分别为-0.29 亿元（+9.72%）、0.48 亿 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative increase in stock price of over 20% compared to the benchmark index within the next six months [7][13]. Core Insights - The company is entering the electronic cleanroom market, which is expected to open a second growth curve. It has established an electronic division in 2024 and won multiple projects, indicating strong growth potential in the semiconductor industry [4]. - The company has formed a strategic partnership with Jiufengshan Laboratory, enhancing its customer acquisition capabilities and integrating into the local semiconductor ecosystem [8]. - The company reported impressive performance in the first three quarters of 2025, with a revenue increase of 32.59% and a net profit increase of 211.46%, driven by the completion of purification system projects [8]. Financial Performance and Forecast - The company forecasts revenues of 25.57 billion, 35.59 billion, and 46.77 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 1.38 billion, 2.12 billion, and 3.35 billion yuan for the same years [5][9]. - The current price-to-earnings (P/E) ratios are projected to be 28.7, 18.8, and 11.9 for 2025, 2026, and 2027 respectively, indicating a decreasing trend in valuation multiples as earnings grow [5][9].

证券日报网讯 1月5日，华康洁净在互动平台回答投资者提问时表示，公司电子洁净室业务作为公司重 要的战略发展方向，正积极有序地推进市场开拓与客户合作。关于该业务的重要客户合作情况，请以公 司在法定信息披露媒体和官方平台发布的内容为准。 （文章来源：证券日报） ...

Group 1 - Ugreen Technology expects a net profit of 653 million to 733 million yuan for 2025, representing a year-on-year growth of 41.26% to 58.56% [1] - SenTai Co. plans to invest no more than 140 million yuan to establish a production base in Vietnam [2] - Muyuan Foods reported a December 2025 sales revenue of 9.667 billion yuan from commodity pigs, a year-on-year decline of 36.06% [3] Group 2 - Pumen Technology has received a medical device registration certificate for a quality control product used in various cancer markers [4] - Heng Rui Medicine's subsidiary has received approval for clinical trials of two injection drugs targeting obesity [5] - Quartz Co. was fined 2.7 million yuan for commercial secret infringement by its subsidiary [6] Group 3 - Chifeng Gold expects a net profit of 3 billion to 3.2 billion yuan for 2025, an increase of approximately 70% to 81% year-on-year [7] - Fulong Technology has terminated the transfer of 82.0969 million shares [8] - Senba Sensor's actual controller has released the pledge of 16.48 million shares [9] Group 4 - Hanma Technology reported a cumulative truck sales increase of 58.45% for 2025 [12] - Guankang Clean won a bid for a special procurement project worth 157 million yuan [14] - Defu Technology signed a cooperation agreement for high-end copper foil supply with a leading CCL company [15] Group 5 - Tianchen Medical signed a strategic cooperation agreement with Inspur Digital Technology [16] - CanSino received approval for clinical trials of a 24-valent pneumococcal polysaccharide conjugate vaccine [17] - Yipin Hong's subsidiary received approval for a supplementary application for oseltamivir phosphate capsules [19] Group 6 - Taotao Vehicle expects a net profit of 800 million to 850 million yuan for 2025, a year-on-year increase of 85.50% to 97.10% [20] - Yutong Bus reported a cumulative sales increase of 5.54% for 2025 [21] - Kingoo Co. received a notification from VinFast to supply automotive wheel products [22] Group 7 - ST Renfu's subsidiary received approval for clinical trials of a new drug for late-stage solid tumors [23] - Nanxing Co. expects a net profit of 90 million to 120 million yuan for 2025, reversing a loss from the previous year [24] - Jinrui Mining's subsidiaries will undergo routine maintenance starting January 5, 2026 [25] Group 8 - Changjiang Power reported a 3.82% increase in total power generation for its six hydropower stations in 2025 [26] - David Medical's subsidiary received a medical device registration certificate for an electronic endoscope image processor [28] - Guiguan Power reported a 26.68% increase in cumulative power generation for 2025 [29] Group 9 - ShenNan Electric's subsidiary won a project worth 208 million USD for a power plant operation service [30] - ST Kaiyuan's major shareholder's shares will be auctioned [31] - Jiecheng Co.'s major shareholder's shares have been auctioned [32] Group 10 - Tongbao Energy's wind power project has begun generating electricity [33] - Xusheng Group received an order worth 7.8 billion yuan from a North American EV manufacturer [34] - Qianli Technology reported a 154.08% increase in December 2025 electric vehicle production [35] Group 11 - Chint Electric plans to issue H-shares and list on the Hong Kong Stock Exchange [36][37] - Whirlpool expects a net profit increase of approximately 150% for 2025 [38] - Yongjie New Materials signed a 2 billion yuan aluminum alloy procurement contract [39]

人民财讯1月5日电，华康洁净（301235）1月5日公告，公司与上海市安装工程集团有限公司组成的联合 体为"惠安县医院分院(一期工程)医院特殊科室采购项目(采购包1)"的中标供应商。该项目中标金额为 1.57亿元，公司作为联合体牵头人，预计份额为7932.2万元，占公司2024年度经审计营业收入的 4.64%。 ...

智通财经APP讯，华康洁净(301235.SZ)公告，公司与上海市安装工程集团有限公司组成的联合体获确认 为"惠安县医院分院(一期工程)医院特殊科室采购项目(采购包1)"的中标供应商，中标金额约1.57亿元。 ...